Total trials
81
Active
16
Phase 3
4
Total enrollment
61,486
Pipeline matrix
Showing 2 of 2 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Blood sampling | — | — | — | — | — | 1 | |
| Urinary test | — | — | — | — | — | 1 |
Next readouts
- 2026-09-30
Top conditions
- Heart Failure8
- Myocardial Infarction4
- Atrial Fibrillation3
- Acute Myocardial Infarction3
- Acute Coronary Syndrome3
- Cardiovascular Diseases3
- Heart Failure With Preserved Ejection Fraction2
- Acute Heart Failure2
Frequently asked questions about French Cardiology Society
- How many clinical trials does French Cardiology Society have on ClinicalTrials.gov?
- French Cardiology Society is listed as the lead sponsor on 81 clinical trials in ClinicalTrials.gov, 16 of which are currently active (recruiting, enrolling, or ongoing).
- How many of French Cardiology Society's trials are in Phase 3?
- 4 of French Cardiology Society's trials are in Phase 3, spread across 2 active drug programs.
- What therapeutic areas does French Cardiology Society focus on?
- French Cardiology Society's most-studied conditions on ClinicalTrials.gov are Heart Failure, Myocardial Infarction, Atrial Fibrillation, Acute Myocardial Infarction, Acute Coronary Syndrome.
- When are French Cardiology Society's next clinical trial readouts?
- French Cardiology Society has 1 upcoming primary-completion readout tracked here; the soonest is “Women's Heart: Impact of Ultra-endurance and Hormonal Profile on Cardiac and Systemic Inflammatory Parameters in Female Runners”, expected around 2026-09-30.